Servier and OSE Immunotherapeutics announce enrollment of first patient in Phase 2 Clinical Trial in Sjögren’s Syndrome
All the news from Servier Group
Shanghai ranking: Paris-Saclay University has risen to 13th place!
Servier commits to the preservation of forests with Planète Urgence
Neuroscience: new research partnership for Servier
Mécénat Servier partners with three new associative projects!
Servier partners with BioLabs to open an incubator in Paris-Saclay for early stage life science start-ups
Olivier Laureau confirmed as Second Vice President of EFPIA
PRISM BioLab, a new partner for Servier in immuno-oncology
Parkinson: Servier and Oncodesign announce the selection of a preclinical candidate